A Resilient Health System in Response to Coronavirus Disease 2019: Experiences of Turkey.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
Historique:
received: 28 06 2020
accepted: 12 11 2020
entrez: 25 1 2021
pubmed: 26 1 2021
medline: 3 2 2021
Statut: epublish

Résumé

Turkey's response experience thus far with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic affords the globe and the region a unique opportunity for and distinctive insights into combating this novel virus. The country's pandemic response, having one of the lowest case fatality ratio (2.8%; 52.5 infections/million population), particularly among the elderly (the high-risk group), rising to the occasion to shoulder its long-standing role in global solidarity and humanitarian support by providing personal protective equipment (globally scarce) to many countries in their desperate time of fight against the pandemic while also meeting its own critical domestic needs, stands out. This paper aims to highlight key decisions, actions, and partnerships behind Turkey's successful fight against the SARS-CoV-2 pandemic that have enabled the country to turn the corner, as well as the components of its success story.

Identifiants

pubmed: 33490014
doi: 10.3389/fpubh.2020.577021
pmc: PMC7817944
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

577021

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2021 Keskinkiliç, Shaikh, Tekin, Ursu, Mardinoglu and Mese.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Bekir Keskinkiliç (B)

Ministry of Health (Turkey), Ankara, Turkey.

Irshad Shaikh (I)

World Health Organization (Turkey), Ankara, Turkey.

Ahmet Tekin (A)

Ministry of Health (Turkey), Ankara, Turkey.

Pavel Ursu (P)

World Health Organization (Switzerland), Geneva, Switzerland.

Adil Mardinoglu (A)

Ministry of Health (Turkey), Ankara, Turkey.

Emine Alp Mese (EA)

Ministry of Health (Turkey), Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH